Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael F. Good Istvan Toth |
| Publication date | June 30, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |